Clinical Trial Update: Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating gefitinib as first-line therapy followed by gemcitabine and cisplatin in patients with stage III or stage IV non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gefitinib (Gefitinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED